https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/Novo-Nordisk-A-S-to-initiate-phase-3a-development-of-oral-semaglutide-a-once-daily-oral-GLP-1-ana-20931177/?utm_source=telegram&utm_medium=social&utm_campaign=share